Which description matches Schedule III drugs?

Study for the FIPA 2 Exam 3. Hone your skills with flashcards and multiple choice questions, each question with hints and explanations. Prepare for your exam confidently!

Multiple Choice

Which description matches Schedule III drugs?

Explanation:
Understanding drug scheduling revolves around matching abuse potential, dependence profile, and medical use to a category. For Schedule III, the substance has a lower potential for abuse than drugs in Schedules I and II, but it can still lead to dependence. Specifically, Schedule III is described as having a moderate potential for abuse with the possibility of high psychological dependence or moderate to low physical dependence, and it has an accepted medical use. The description that mentions moderate abuse potential and either high psychological dependence or moderate/low physical dependence aligns with this profile, and it sets Schedule III apart from the other schedules which describe no medical use (Schedule I), higher abuse potential with stronger dependence risks (Schedule II), or lower abuse potential with even less dependence (Schedule IV/V).

Understanding drug scheduling revolves around matching abuse potential, dependence profile, and medical use to a category. For Schedule III, the substance has a lower potential for abuse than drugs in Schedules I and II, but it can still lead to dependence. Specifically, Schedule III is described as having a moderate potential for abuse with the possibility of high psychological dependence or moderate to low physical dependence, and it has an accepted medical use. The description that mentions moderate abuse potential and either high psychological dependence or moderate/low physical dependence aligns with this profile, and it sets Schedule III apart from the other schedules which describe no medical use (Schedule I), higher abuse potential with stronger dependence risks (Schedule II), or lower abuse potential with even less dependence (Schedule IV/V).

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy